Cargando…

Neurogenesis in Neurotoxin-induced Animal Models for Parkinson’s Disease—A Review of the Current Status

Animal models for Parkinson’s disease (PD) are essential for understanding its pathogenesis and for development and testing of new therapies. Discoveries of endogenous neurogenesis in the adult mammalian brain give new insight into the cell-based approach for treatment of neurodegenerative disorders...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xi Jun, Nakayama, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Toxicologic Pathology 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246055/ https://www.ncbi.nlm.nih.gov/pubmed/22271983 http://dx.doi.org/10.1293/tox.22.101

Ejemplares similares

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
por: Prasad, E. Maruthi, et al.
Publicado: (2020)

Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
por: Zeng, Xian-Si, et al.
Publicado: (2018)

Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease
por: Zhao, Xin, et al.
Publicado: (2013)

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal
por: Mou, Ya-Kui, et al.
Publicado: (2022)

Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease
por: Ren, Rutong, et al.
Publicado: (2016)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing
por: Pellett, Sabine, et al.
Publicado: (2015)

Botulinum Neurotoxin for Pain Management: Insights from Animal Models
por: Pavone, Flaminia, et al.
Publicado: (2010)

Early Postnatal but Not Late Adult Neurogenesis Is Impaired in the Pitx3-Mutant Animal Model of Parkinson's Disease
por: Brandt, Moritz D., et al.
Publicado: (2017)

Photobiomodulation regulates adult neurogenesis in the hippocampus in a status epilepticus animal model
por: Hong, Namgue, et al.
Publicado: (2022)

Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson’s Disease: An Updated Review
por: Mitchell, Steven D., et al.
Publicado: (2021)

Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal
por: Jost, Wolfgang H.
Publicado: (2021)

High content imaging quantification of multiple in vitro human neurogenesis events after neurotoxin exposure
por: Wu, Xian, et al.
Publicado: (2016)

Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s Disease
por: Chinta, Shankar J., et al.
Publicado: (2018)

Neuroprotective effect of Ginsenoside Re against neurotoxin-induced Parkinson's disease models via induction of Nrf2
por: Qiao, Juhui, et al.
Publicado: (2022)

Hydrogen sulfide enhances adult neurogenesis in a mouse model of Parkinson’s disease
por: Wang, Min, et al.
Publicado: (2020)

Do changes in microglial status underlie neurogenesis impairments and depressive-like behaviours induced by psychological stress? A systematic review in animal models
por: Nieto-Quero, Andrea, et al.
Publicado: (2021)

Effects of treadmill exercise on hippocampal neurogenesis in an MPTP /probenecid-induced Parkinson’s disease mouse model
por: Sung, Yun-Hee
Publicado: (2015)

NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
por: Anantha, Jayanth, et al.
Publicado: (2021)

Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s Disease
por: Chiu, Ya-Jen, et al.
Publicado: (2023)

Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera
por: Babrak, Lmar, et al.
Publicado: (2016)

Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy
por: Luvisetto, Siro
Publicado: (2021)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Botulinum Neurotoxin A Injections Influence Stretching of the Gastrocnemius Muscle-Tendon Unit in an Animal Model
por: Haubruck, Patrick, et al.
Publicado: (2012)

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

The Metal Neurotoxins: An Important Role in Current Human Neural Epidemics?
por: Schofield, Keith
Publicado: (2017)

The current status of gene therapy for Parkinson's disease
por: Muramatsu, Shin-ichi
Publicado: (2010)

Status of Current Biofluid Biomarkers in Parkinson's Disease
por: Mollenhauer, Brit
Publicado: (2023)

Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis
por: Ermine, Charlotte M., et al.
Publicado: (2018)

Novel Approaches Used to Examine and Control Neurogenesis in Parkinson′s Disease
por: Salmina, Alla B., et al.
Publicado: (2021)

Comparison of Sea Snake (Hydrophiidae) Neurotoxin to Cobra (Naja) Neurotoxin
por: Komori, Yumiko, et al.
Publicado: (2009)

Photobiomodulation for Parkinson’s Disease in Animal Models: A Systematic Review
por: Salehpour, Farzad, et al.
Publicado: (2020)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Animal Models of Parkinson's Disease 2012
por: Imai, Yuzuru, et al.
Publicado: (2012)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Animal Model for Prodromal Parkinson’s Disease
por: Taguchi, Tomoyuki, et al.
Publicado: (2020)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments
por: Chen, Sheng
Publicado: (2012)

Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function
por: Han, Myung-Hoon, et al.
Publicado: (2016)

Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
por: Antipova, Veronica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9nkmcrbkjpbknaqnps44hsogr1